Concurrent inhibition of the RAS ERK-MAPK pathway and PIKfyve as a therapeutic strategy for pancreatic cancer

被引：0
|
作者：
DeLiberty, Jonathan M.
Roach, Mallory K.
Stalnecker, Clint A.
Robb, Ryan
Schechter, Elyse G.
Pieper, Noah L.
Yang, Runying
Bang, Scott
Taylor, Khalilah E.
Drizyte-Miller, Kristina
Morris, John P.
Der, Channing J.
Cox, Adrienne D.
Bryant, Kirsten L.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 17期
关键词：
D O I：
10.1158/1538-7445.PANCREATIC24-C026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C026
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Spred2 deficiency accelerates cancer growth, migration and invasion in HepG2 cells via activating ERK-MAPK pathway
    Gao, T.
    Yang, X.
    Yoshimura, T.
    Fujisawa, M.
    Ohara, T.
    Matsukawa, A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 74 - 75
  • [42] Anti-Metastatic Effects of Lupeol via the Inhibition of MAPK/ERK Pathway in Lung Cancer
    Bhatt, Mital
    Patel, Mitesh
    Adnan, Mohd
    Reddy, Mandadi N.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021, 21 (02) : 201 - 206
  • [43] The ERK/MAPK pathway is overexpressed and activated in gallbladder cancer
    Buchegger, Kurt
    Silva, Ramon
    Lopez, Jaime
    Ili, Carmen
    Carlos Araya, Juan
    Leal, Pamela
    Brebi, Priscilla
    Riquelme, Ismael
    Carlos Roa, Juan
    PATHOLOGY RESEARCH AND PRACTICE, 2017, 213 (05) : 476 - 482
  • [44] Targeting the Ras-MAPK pathway for cancer therapy
    Luo, J.
    ANNALS OF ONCOLOGY, 2011, 22 : 14 - 14
  • [45] hSef co-localizes and interacts with Ras in the inhibition of Ras/MAPK signaling pathway
    Ren, Yongming
    Cheng, Long
    Rong, Zhili
    Li, Zhiyong
    Li, Yinghua
    Li, Hongge
    Wang, Zhen
    Chang, Zhijie
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 347 (04) : 988 - 993
  • [46] Prevalence and patterns of mutations in RAS/RAF/MEK/ERK/MAPK signaling pathway in colorectal cancer in North Africa
    Meryem Jafari
    Abdelilah Laraqui
    Walid Baba
    Soukaina Benmokhtar
    Sara El Zaitouni
    Abdelmounaim Ait Ali
    Ahmed Bounaim
    Mountassir Moujahid
    Rachid Tanz
    Tarik Mahfoud
    Yassir Sbitti
    Hicham El Annaz
    Rachid Abi
    Mohamed Rida Tagajdid
    Safae El Kochri
    Idriss Amine Lahlou
    Houda El Hsaini
    Lamiae Belayachi
    Abdelaziz Benjouad
    Mohammed Ichou
    Amina En-Nya
    Khalid Ennibi
    BMC Cancer, 22
  • [47] Prevalence and patterns of mutations in RAS/RAF/MEK/ERK/MAPK signaling pathway in colorectal cancer in North Africa
    Jafari, Meryem
    Laraqui, Abdelilah
    Baba, Walid
    Benmokhtar, Soukaina
    El Zaitouni, Sara
    Ali, Abdelmounaim Ait
    Bounaim, Ahmed
    Moujahid, Mountassir
    Tanz, Rachid
    Mahfoud, Tarik
    Sbitti, Yassir
    El Annaz, Hicham
    Abi, Rachid
    Tagajdid, Mohamed Rida
    El Kochri, Safae
    Lahlou, Idriss Amine
    El Hsaini, Houda
    Belayachi, Lamiae
    Benjouad, Abdelaziz
    Ichou, Mohammed
    En-Nya, Amina
    Ennibi, Khalid
    BMC CANCER, 2022, 22 (01)
  • [48] Triiodothyronine Induces Proliferation of Pancreatic β-cells through the MAPK/ERK Pathway
    Kim, T. K.
    Lee, J. S.
    Jung, H. S.
    Ha, T. K.
    Kim, S. M.
    Han, N.
    Lee, E. J.
    Kim, T. N.
    Kwon, M. J.
    Lee, S. H.
    Kim, M. K.
    Rhee, B. D.
    Park, J. H.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (04) : 240 - 245
  • [49] Phosphatase activation and kinase inhibition as a novel therapeutic strategy for pancreatic cancer
    Allen-Petersen, Brittany L.
    Farrell, Amy S.
    Daniel, Colin J.
    Wang, Zhiping
    Lopez, Charles D.
    Christensen, Dale J.
    Sheppard, Brett C.
    Sears, Rosalie C.
    CANCER RESEARCH, 2015, 75
  • [50] Inhibition of SIRT1 as a Novel Therapeutic Strategy for Pancreatic Cancer
    Dudeja, V.
    Chugh, R.
    Skube, S.
    Bezek, H. M.
    Majumdar, N.
    Yokoyama, Y.
    Borja-Cacho, D.
    Dawra, R.
    Vickers, S.
    Saluja, A.
    PANCREAS, 2009, 38 (08) : 993 - 993
12345